Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Other Current Assets

Current assets not reported separately, such as prepaid expenses.

No reported Other Current Assets figures are available to summarize.

Other Current Assets history

Currency unavailable · from the balance sheet

No Other Current Assets data reported for this period type.

Other Current Assets vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Other Current Assets for KARD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NAMSNewAmsterdam Pharma Company N.V.Jun 2026$1.36M USD-93.1%-13.9%0.2%
IKTInhibikase Therapeutics, Inc.Mar 2026$1.29M USD+1568.7%-32.5%0.7%
RNAAtrium Therapeutics, Inc.Mar 2026$138K USD——0.0%
TNYATenaya Therapeutics, Inc.Mar 2026$25K USD-98.0%+3.0%0.0%
CYTKCytokinetics, IncorporatedJun 2026$0 USD—+10.9%0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-93.1%-5.5%0.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.